Unknown

Dataset Information

0

Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs.


ABSTRACT: Coxsackievirus B3 (CVB3) is a common pathogen of myocarditis. We previously synthesized a siRNA targeting the CVB3 protease 2A (siRNA/2A) gene and achieved reduction of CVB3 replication by 92% in vitro. However, like other drugs under development, CVB3 siRNA faces a major challenge of targeted delivery. In this study, we investigated a novel approach to deliver CVB3 siRNAs to a specific cell population (e.g. HeLa cells containing folate receptor) using receptor ligand (folate)-linked packaging RNA (pRNA) from bacterial phage phi29. pRNA monomers can spontaneously form dimers and multimers under optimal conditions by base-pairing between their stem loops. By covalently linking a fluorescence-tag to folate, we delivered the conjugate specifically to HeLa cells without the need of transfection. We further demonstrated that pRNA covalently conjugated to siRNA/2A achieved an equivalent antiviral effect to that of the siRNA/2A alone. Finally, the drug targeted delivery was further evaluated by using pRNA monomers or dimers, which carried both the siRNA/2A and folate ligand and demonstrated that both of them strongly inhibited CVB3 replication. These data indicate that pRNA as a siRNA carrier can specifically deliver the drug to target cells via its ligand and specific receptor interaction and inhibit virus replication effectively.

SUBMITTER: Zhang HM 

PROVIDER: S-EPMC3909712 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3115994 | biostudies-literature
| S-EPMC9122583 | biostudies-literature
| S-EPMC4674642 | biostudies-literature
| S-EPMC5023400 | biostudies-literature
| S-EPMC4754549 | biostudies-literature
| S-EPMC7114402 | biostudies-literature
| S-EPMC7452223 | biostudies-literature
| S-EPMC4003007 | biostudies-other
| S-EPMC6118344 | biostudies-literature
| S-EPMC5811376 | biostudies-literature